Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4

Shaomin Tian1, Won-Tak Choi, Dongxiang Liu

  • 1Departments of Biochemistry, University of Illnois at Urbana-Champaign, 61801, USA.

Journal of Virology
|September 29, 2005
PubMed

Insights

Researchers identified specific transmembrane regions of CXCR4 crucial for HIV-1 entry, distinct from SDF-1alpha binding sites. This finding offers a new strategy for developing selective anti-HIV therapies targeting viral entry mechanisms.

Area of Science:

  • Virology
  • Cell Biology
  • Structural Biology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) entry relies on interactions with CD4 and chemokine coreceptors like CXCR4.
  • While extracellular interactions are known, the role of CXCR4's transmembrane (TM) domains in HIV-1 entry and SDF-1alpha binding remains unclear.

Purpose of the Study:

  • To investigate the functional roles of CXCR4 transmembrane helices in HIV-1 entry and SDF-1alpha binding.
  • To determine if these roles are overlapping or distinct for physiological and pathological functions.

Main Methods:

  • Alanine-scanning mutagenesis of CXCR4.
  • Competition binding assays with radiolabeled SDF-1alpha.
  • Calcium (Ca2+) mobilization assays.
  • Cell-cell fusion assays to measure HIV-1 entry.

Main Results:

  • Mutations in several CXCR4 TM residues selectively impaired HIV-1-mediated cell fusion without affecting SDF-1alpha binding.
  • Specific residues (Phe87, Phe292) involved in SDF-1alpha binding did not significantly impact CXCR4 coreceptor activity for HIV-1.
  • Mutations in the second extracellular loop also reduced HIV-1 entry without affecting ligand binding or signaling.

Conclusions:

  • CXCR4 transmembrane domains possess distinct functional sites for HIV-1 entry and SDF-1alpha binding.
  • These findings provide a mechanistic basis for developing novel, selective anti-HIV agents targeting viral entry.